跳至主要内容
临床试验/ACTRN12620000502932
ACTRN12620000502932已完成未知

CAMERA-MRI II trial: Catheter Ablation versus Medical Rate Control of Atrial Fibrillation with Systolic Heart Failure and Myocardial Fibrosis – an MRI Guided Multi-Centre Randomised Controlled Clinical Trial

Alfred Hospital0 个研究点目标入组 120 人开始时间: 2020年4月22日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Patients aged 18 years or older with AF and HF (LVEF 45% or below on CMR) who have trialled and failed at least 1 anti-arrhythmic agent or experienced AF recurrence following electrical cardioversion (DCR)

排除标准

  • -CMR contraindication (eGFR <35mL/min, MRI-incompatible device)
  • -Catheter ablation contraindications such as ASD closure, LAA thrombus, anticoagulation contraindication
  • -AF >5yrs (where sinus rhythm is unlikely to be achieved or maintained)
  • -LVEF > 45% (CMR)
  • -Valvular AF
  • -Specific reversible HF aetiology (uncontrolled thyroid disease, excessive alcohol, myocarditis)
  • Within 3 months of planned cardiac intervention (PCI/CABG/implantable cardiac device) or planned intervention within 12 months of study enrolment.

研究者

发起方
Alfred Hospital

相似试验